Well I'm looking at buying AMRN. I already own two bios and heavily in one (ATRS). But I'm intrigued by the PPS at just above 5. Is Vascepa gonna be a success? I started looking at some Medicare Part D formulary and did find Vascepa as a preferred brand drug for CIP or Care Improvement plus now owned by United Health Care. This should be encouraging but I also found that Vascepa is not on Wellcare or Coventry's formulary for now. I am going to check out where they are on Humana's and AARP formulary. AARP pop 's are also underwritten by UHC.
That's they key to the success of this drug making $$$$, and that is getting on the 'preferred brand" copayment schedule and not a tier 3 non preferred or not on the formulary at all.
Bingo Foogie, and that's happening. Talked with a friend at HCSC and although he wasn't sure, he did say the Aetna coverage likely means HCSC would follow along shortly as they have done so in the past. HCSC owns BCBS OK, NM, TX and IL. Once those are on board all the Blues should follow and the rest of the insurance universe, like Coventry. By January 2014 nearly every insurer will have them listed as preferred and with ANCHOR approval Lovaza coverage will be discriminated against in the ANCHOR population or even not covered at all. The things the market isn't considering regarding AMRN are remarkable. Oh, and Vascepa blood work and side effects beat the tar out of Lovaza with no afib warning.